Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lucena

Showing results (131-140 of 165) with videos related to

Pageof 17
Sort By:
British Journal of Haematology|December 28, 2016
The experience of the International Consortium on Acute Promyelocytic Leukemia in monitoring minimal residual disease in acute promyelocytic leukaemiaAna P Lange, Ana S Lima, Antonio R Lucena-Araujo, et al.
Blood|August 31, 2015
Clinical outcomes of patients with acute myeloid leukemia: evaluation of genetic and molecular findings in a real-life settingAleide S Lima, Mariana R de Mello, Eliana Fernandes, et al.
Toxicon : Official Journal of the International Society on Toxinology|September 19, 2022
Acetogenin-induced fibrotic heart disease from avocado (Persea americana, Lauraceae) poisoning in horsesMarina S Freitas, Asheley H B Pereira, Gabriela O Pereira, et al.
Hematology, Transfusion and Cell Therapy|February 2, 2024
Functional characterization of compound heterozygosity Hb S/Hb Deer Lodge in BrazilMarcondes J Sobreira, Thais H Batista, Rodrigo M Santana, et al.
British Journal of Haematology|April 16, 2026
A genetic risk score based on BCL11A and HBS1L-MYB variants predicts clinical severity in Brazilian sickle cell anaemia patientsGabriela S Arcanjo, Alexsandro P Silva, Madi V Diniz, et al.
Annals of Hematology|November 19, 2009
Results of FLT3 mutation screening and correlations with immunophenotyping in 169 Brazilian patients with acute myeloid leukemiaAntonio R Lucena-Araujo, Danielle L Souza, Fabio Morato de Oliveira, et al.
Hematology, Transfusion and Cell Therapy|July 1, 2023
Prognostic implications of the ID1 expression in acute myeloid leukemia patients treated in a resource-constrained settingAleide S Lima, Matheus F Bezerra, Amanda Moreira-Aguiar, et al.
British Journal of Haematology|February 26, 2016
Prognostic importance of CD56 expression in intermediate risk acute myeloid leukaemiaJuan L Coelho-Silva, Luany E Carvalho, Mayara M Oliveira, et al.
Oncotarget|December 31, 2016
ΔNp73 overexpression promotes resistance to apoptosis but does not cooperate with PML/RARA in the induction of an APL-leukemic phenotypeAntonio R Lucena-Araujo, Juan L Coelho-Silva, Diego A Pereira-Martins, et al.
Expert Opinion on Drug Delivery|July 22, 2010
Controlled transscleral drug delivery formulations to the eye: establishing new concepts and paradigms in ocular anti-inflammatory therapeutics and antibacterial prophylaxisFernando Paganelli, José A Cardillo, Alessandro R J Dare, et al.
Pageof 17

Showing results (131-140 of 165) with videos related to

Sort By:
Pageof 17
British Journal of Haematology|December 28, 2016
The experience of the International Consortium on Acute Promyelocytic Leukemia in monitoring minimal residual disease in acute promyelocytic leukaemiaAna P Lange, Ana S Lima, Antonio R Lucena-Araujo, et al.
Blood|August 31, 2015
Clinical outcomes of patients with acute myeloid leukemia: evaluation of genetic and molecular findings in a real-life settingAleide S Lima, Mariana R de Mello, Eliana Fernandes, et al.
Toxicon : Official Journal of the International Society on Toxinology|September 19, 2022
Acetogenin-induced fibrotic heart disease from avocado (Persea americana, Lauraceae) poisoning in horsesMarina S Freitas, Asheley H B Pereira, Gabriela O Pereira, et al.
Hematology, Transfusion and Cell Therapy|February 2, 2024
Functional characterization of compound heterozygosity Hb S/Hb Deer Lodge in BrazilMarcondes J Sobreira, Thais H Batista, Rodrigo M Santana, et al.
British Journal of Haematology|April 16, 2026
A genetic risk score based on BCL11A and HBS1L-MYB variants predicts clinical severity in Brazilian sickle cell anaemia patientsGabriela S Arcanjo, Alexsandro P Silva, Madi V Diniz, et al.
Annals of Hematology|November 19, 2009
Results of FLT3 mutation screening and correlations with immunophenotyping in 169 Brazilian patients with acute myeloid leukemiaAntonio R Lucena-Araujo, Danielle L Souza, Fabio Morato de Oliveira, et al.
Hematology, Transfusion and Cell Therapy|July 1, 2023
Prognostic implications of the ID1 expression in acute myeloid leukemia patients treated in a resource-constrained settingAleide S Lima, Matheus F Bezerra, Amanda Moreira-Aguiar, et al.
British Journal of Haematology|February 26, 2016
Prognostic importance of CD56 expression in intermediate risk acute myeloid leukaemiaJuan L Coelho-Silva, Luany E Carvalho, Mayara M Oliveira, et al.
Oncotarget|December 31, 2016
ΔNp73 overexpression promotes resistance to apoptosis but does not cooperate with PML/RARA in the induction of an APL-leukemic phenotypeAntonio R Lucena-Araujo, Juan L Coelho-Silva, Diego A Pereira-Martins, et al.
Expert Opinion on Drug Delivery|July 22, 2010
Controlled transscleral drug delivery formulations to the eye: establishing new concepts and paradigms in ocular anti-inflammatory therapeutics and antibacterial prophylaxisFernando Paganelli, José A Cardillo, Alessandro R J Dare, et al.
Pageof 17